Parker v. Alcon Management S. A.

CourtDistrict Court, N.D. Alabama
DecidedSeptember 22, 2021
Docket2:20-cv-01894
StatusUnknown

This text of Parker v. Alcon Management S. A. (Parker v. Alcon Management S. A.) is published on Counsel Stack Legal Research, covering District Court, N.D. Alabama primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Parker v. Alcon Management S. A., (N.D. Ala. 2021).

Opinion

UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ALABAMA SOUTHERN DIVISION ANNIE PARKER ) ) Plaintiff, ) ) 2:20-cv-01894- LSC v. ) ) ALCON, INC. d/b/a ) ALCON LABORATORIES, INC. ) ) Defendant. ) MEMORANDUM OF OPINION Before the Court is Defendant Alcon Inc.’s (“Alcon” or “Defendant”) Motion to Dismiss for lack of personal jurisdiction, improper service, and failure to state a claim upon which relief can be granted. (Doc. 8) For the reasons stated below, Defendant’s Motion to Dismiss (Doc. 8) is due to be GRANTED, and Plaintiff’s requests for jurisdictional discovery and leave to amend (Doc. 14.) are due to be DENIED. I. BACKGROUND Plaintiff, Annie Parker (“Parker” or “Plaintiff”) is a 78-year-old woman and

a citizen of Jefferson County, Alabama. (Doc. 4 at 1, 7.) Defendant Alcon is a corporation organized under the laws of Switzerland, with its principal place of business in Fribourg, Switzerland. (Doc. 8–1 at 2.)

Parker has glaucoma in both eyes. (Doc. 4 at 7.) After meeting with a doctor, it was decided that she would undergo cataract surgery that would also involve implanting in both eyes the CyPass Micro-Stent, a medical device that is inserted

into the eye to relieve glaucoma-caused eye pressure that can lead to optic nerve damage. Parker alleges that the CyPass Micro-Stents were designed, manufactured, and sold by Defendant. (Doc. 4 at 3, 7.) On October 24, 2017, Parker underwent the

surgery, and the night after complained of pain, headaches, sensitivity to light, and itchiness. (Doc. 4 at 7.) At an unspecified time between October 24, 2017, and November 28, 2018, Plaintiff visited another doctor for a second opinion, who

recommended that the CyPass Micro-Stents be removed. Id. On August 29, 2018, there was a worldwide recall of the CyPass Micro-Stent after a study indicated that the device could damage cells in the eye. (Doc. 4 at 6.) On November 28, 2018,

Plaintiff underwent the recommended surgery to remove the CyPass Micro-Stents. (Doc. 4 at 7.) Plaintiff subsequently filed suit against Defendant. Plaintiff filed her

Complaint on November 29, 2020. (Doc. 1.) Plaintiff then filed the First Amended Complaint on December 24, 2020. (Doc. 2.) On January 8, 2021, Plaintiff filed the Second Amended Complaint (“SAC”) without asking for consent from Defendant or leave from the Court. (Doc. 4.) Defendant then filed its motion to dismiss on

February 9, 2021. (Doc. 8.) Plaintiff responded to Defendant’s motion on March 6, 2021. (Doc. 14.) Plaintiff’s response requested that the motion to dismiss be denied, but in the alternative asked for an opportunity to conduct discovery or to have leave

to amend. Id. Defendant filed its reply on March 15, 2021. (Doc. 19.) In its motion to dismiss, Defendant argues that Alcon is not subject to personal jurisdiction in Alabama. (Doc. 8 at 2.) In the SAC, Parker alleges that Alcon is a

Delaware corporation with its principal place of business in Texas, and further asserts that Alcon does business as “Alcon Laboratories, Inc.” (“Laboratories”). (Doc. 4 at 1.) Parker further alleges that “defendant continuously and systematically

does business with the Northern District of Alabama.” Id. at 2. Alcon contests this allegation, asserting that they are a Swiss corporation, and that Laboratories is actually a wholly owned subsidiary of Alcon, and that the two are

separate corporate entities. In support of this argument, Alcon submitted an affidavit from Jean-Baptiste Emery (“Emery”). (Doc. 8–1.) Emery is the Executive Director of Alcon, which he asserts is a corporation organized under the laws of Switzerland

with its principal place of business in Fribourg, Switzerland. Id. at 1. Emery states that “Alcon has never done business as Alcon Laboratories, Inc.,” that “Alcon Laboratories, Inc. is a wholly-owned subsidiary of Alcon,” and that “Alcon and Alcon Laboratories, Inc. are separate corporate entities.” Id. at 2. Emery further

states that Alcon “does not conduct, and has never conducted, business anywhere in the state of Alabama.” Id. at 3. Finally, Emery states, “Alcon has never maintained a national market in the United States” and that Alcon “has never marketed,

promoted, distributed or sold any product” in “the State of Alabama or any other State or United States territory.” Id. In responding to Emery’s affidavit and to further establish personal

jurisdiction over Alcon, Parker submitted a page from the Delaware Secretary of State’s website that shows an “Alcon Incorporated” as being incorporated in Delaware. (Doc. 14-1.) Additionally, Parker submitted a filing from the US Securities

and Exchange Commission (“SEC”) which shows that “Alcon Inc” has its principal executive offices in Fort Worth, Texas. (Doc. 14-2.) In response to these submissions by Parker, Alcon provided a reply in support

of its motion to dismiss. To rebut the SEC filing, Alcon asserts in its reply that the filing was not done by them but rather a third-party, and that the provided address was incorrect. Additionally, to rebut the Delaware Secretary of State’s website page,

Alcon’s reply includes a declaration from Sharon Woods (“Woods”). (Doc. 19–2.) Woods is the Manager of Corporate Data, Governance and Securities at Alcon Vision, LLC (“Vision”), an indirect subsidiary of Alcon, and her position provides “access to the current and historical corporate records and information pertaining

to Alcon Vision, LLC and all other subsidiaries or affiliated entities of Alcon Inc. in the United States.” Id. at 2. Woods’s declaration states that the Alcon Incorporated referred to on the Delaware Secretary of State’s website page that Parker submitted

“is not and has never been affiliated in any way with [Defendant] Alcon.” Id. at 3. II. STANDARD OF REVIEW A. PERSONAL JURISDICTION

In a Rule 12(b)(2) motion to dismiss, the plaintiff has the initial burden to show that the Court has personal jurisdiction over the defendant. Meier ex rel. Meier v. Sun Int'l Hotels, Ltd., 288 F.3d 1264, 1268-69 (11th Cir. 2002). The plaintiff must allege

“sufficient facts to make out a prima facie case of jurisdiction.” Estate of Scutieri v. Chambers, 386 F. App'x 951, 956 (11th Cir. 2010). Conclusory allegations are insufficient. Meier, 288 F.3d at 1269. “A prima facie case is established if the plaintiff

presents enough evidence to withstand a motion for directed verdict.” Madara v. Hall, 916 F.2d 1510, 1514 (11th Cir. 1990). Once the plaintiff establishes a prima facie case of jurisdiction, the burden shifts to the defendant to challenge those allegations.

Meier, 288 F.3d at 1269. If the defendant submits affidavits challenging jurisdiction, the burden then shifts back to the plaintiff to substantiate the allegations in the complaint with evidence supporting jurisdiction. Id. Where, as here, the defendant has supported its jurisdictional challenge with affidavits, the plaintiff “bears the

burden of proving ‘by affidavit the basis upon which jurisdiction may be obtained.’” Posner, 178 F.3d at 1214. Ultimately, reasonable inferences are drawn in the plaintiff's favor if the evidence conflicts. Madara, 916 F.2d at 1514.

A federal district court “may exercise personal jurisdiction to the extent authorized by the law of the state in which it sits and to the extent allowed under the Constitution.” Meier ex rel. Meier v. Sun Int’l Hotels, Ltd., 288 F.3d 1264, 1269 (11th

Cir. 2002); see also Daimler AG v. Bauman, 571 U.S. 117, 125 (2014).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Meier Ex Rel. Meier v. Sun International Hotels, Ltd.
288 F.3d 1264 (Eleventh Circuit, 2002)
Mutual Service Insurance v. Frit Industries, Inc.
358 F.3d 1312 (Eleventh Circuit, 2004)
Sloss Industries Corporation v. Eurisol
488 F.3d 922 (Eleventh Circuit, 2007)
Licciardello v. Lovelady
544 F.3d 1280 (Eleventh Circuit, 2008)
United Technologies Corp. v. Mazer
556 F.3d 1260 (Eleventh Circuit, 2009)
Milliken v. Meyer
311 U.S. 457 (Supreme Court, 1941)
International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
McGee v. International Life Insurance
355 U.S. 220 (Supreme Court, 1957)
Shaffer v. Heitner
433 U.S. 186 (Supreme Court, 1977)
Keeton v. Hustler Magazine, Inc.
465 U.S. 770 (Supreme Court, 1984)
Goodyear Dunlop Tires Operations, S. A. v. Brown
131 S. Ct. 2846 (Supreme Court, 2011)
John Madara v. Daryl Hall
916 F.2d 1510 (Eleventh Circuit, 1990)
Daimler AG v. Bauman
134 S. Ct. 746 (Supreme Court, 2014)
Walden v. Fiore
134 S. Ct. 1115 (Supreme Court, 2014)
Ex parte Edgetech I.G., Inc. n/k/a Quanex I.G. Systems, Inc.
159 So. 3d 629 (Supreme Court of Alabama, 2014)
Tawana Carmouche v. Tamborlee Management, Inc.
789 F.3d 1201 (Eleventh Circuit, 2015)
Estate of Philip Scutieri v. Raymond G. Chambers
386 F. App'x 951 (Eleventh Circuit, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
Parker v. Alcon Management S. A., Counsel Stack Legal Research, https://law.counselstack.com/opinion/parker-v-alcon-management-s-a-alnd-2021.